Therefore, we aimed to experimentally determine whether it was possible for the mesenchymal-like MDA-MB-231 breast cancer cells to undergo an MErT through the re-expression of E-cadherin, either through exogenous introduction or through induction by the microenvironment. The gene discussed is CDH1; the disease is breast cancer.